Cepheid Discloses Further Terms of HIV Test Pact with FIND | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today formally announced a collaboration with the Foundation for Innovative New Diagnostics to co-develop a molecular test for measuring HIV viral load.

The company originally disclosed the collaboration during Cepheid's fourth-quarter and full-year 2010 earnings conference call last week. Today's announcement provides further details about the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.